This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Cheung, A. T. Articles by Meng, Q. C. Search for Related Content PubMed PubMed Citation Articles by Cheung, A. T. Articles by Meng, Q. C.

---

CARDIOVASCULAR ANESTHESIA

Nicardipine Intravenous Bolus Dosing for Acutely Decreasing Arterial Blood Pressure During General Anesthesia for Cardiac Operations: Pharmacokinetics, Pharmacodynamics, and Associated Effects on Left Ventricular Function

Department of Anesthesia, University of Pennsylvania, Philadelphia, Pennsylvania

Address correspondence and reprint requests to Albert T. Cheung, MD, Department of Anesthesia, Dulles 7, University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104-4283. Address e-mail to cheungal{at}mail.med.upenn.edu

The objective of this study was to evaluate the efficacy of nicardipine, a dihydropyridine calcium channel antagonist, administered as an IV bolus dose to acutely decrease arterial pressure in anesthetized cardiac surgical patients. We performed a double-blind, randomized, self-controlled, dose-ranging study in 40 adult cardiac surgical patients to determine the pharmacokinetics and pharmacodynamics of nicardipine 0.25 mg, 0.50 mg, 1.00 mg, and 2.00 mg administered as an IV bolus. Transesophageal echocardiography was used to assess left ventricular preload, afterload, and global systolic function. Plasma nicardipine concentration was measured using high-performance liquid chromatography. Nicardipine selectively decreased arterial pressure in a dose-dependent manner with a maximum response within 100 s and recovery to half the maximum response within 3–7 min without associated changes in heart rate. The decreases in arterial pressure were associated with only small decreases in left ventricular end-systolic wall stress and small increases in global left ventricular systolic function without changes in left ventricular end-diastolic cavity area or cardiac output. The time course for nicardipine bolus was consistent with a two-compartment pharmacokinetic model with rapid redistribution from a small central compartment.

Implications: Nicardipine was effective for selectively decreasing arterial blood pressure acutely, but had no effects on ventricular preload or cardiac output. The absence of dose-dependent changes in cardiac output, left ventricular systolic performance, and left ventricular afterload despite significant decreases in arterial pressure suggested that nicardipine had a small negative inotropic action.

This article has been cited by other articles:

				D. Rhoney and W. F. Peacock Intravenous therapy for hypertensive emergencies, part 1 Am. J. Health Syst. Pharm., August 1, 2009; 66(15): 1343 - 1352. [Abstract] [Full Text] [PDF]

				R. A. Kross, E. Ferri, D. Leung, M. Pratila, C. Broad, M. Veronesi, and J. A. Melendez A Comparative Study Between a Calcium Channel Blocker (Nicardipine) and a Combined {alpha}-{beta}-Blocker (Labetalol) for the Control of Emergence Hypertension During Craniotomy for Tumor Surgery Anesth. Analg., October 1, 2000; 91(4): 904 - 909. [Abstract] [Full Text] [PDF]